Downregulation of TUSC3 Promotes EMT and Hepatocellular Carcinoma Progression through LIPC/AKT Axis

Loss-of-function and gain-of-function were applied to detect the function of Tumor Suppressor Candidate 3 (TUSC3) and lipase C hepatic type (LIPC) in vivo and in vitro.